Dr Ateequllah Hayat is a lecturer in Drug Development on the Clinical Pharmacology BSc. He is the module lead for Year 1 and 2 Drug Development and contributes to teaching across the BSc including Year 3 Disease and Drug Targets A, Data and Statistics and Hot Topics. He also contributes to teaching on Biomedical Science BSc and Translational Medicine MRes.

Dr Ateequllah Hayat is an academic scientist with industry experience who obtained his PhD in Molecular Biology from Barts Cancer Institute, Queen Mary University of London. There he developed an in vitro breast cancer model to characterise signalling and epigenetic changes at the very onset of breast cancer progression. He then joined Imperial College London working with Myricx Pharma Limited, where he characterised compounds to target a post-translational modification in various cancers. Whilst molecular biologist by training, he is deeply interested in how drugs are developed with a passion for bioinformatics/genomics and analysis of next generation sequencing data.

Research interests: Understanding the differences in epigenetic changes, particularly the chromatin dynamics, between cancer and cancer resistant cells and the targeting of novel cancer-associated chromatin regulators with drugs.